These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9848452)
21. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811 [TBL] [Abstract][Full Text] [Related]
22. [Drug sensitivity of Helicobacter pylori strains in children and young people from the region of Łódź]. Bak-Romaniszyn L; Planeta-Malecka I; Czkwianianc E; Rozynek E; Dzierzanowska D; Laszewicz W Med Wieku Rozwoj; 2003; 7(2):129-35. PubMed ID: 12878783 [TBL] [Abstract][Full Text] [Related]
23. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100 [TBL] [Abstract][Full Text] [Related]
25. High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia. Goh KL; Navaratnam P Helicobacter; 2011 Jun; 16(3):241-5. PubMed ID: 21585611 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005 [TBL] [Abstract][Full Text] [Related]
28. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022 [TBL] [Abstract][Full Text] [Related]
29. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children. Rozynek E; Dzierzanowska-Fangrat K; Celińska-Cedro D; Jóźwiak P; Madaliński K; Dzierzanowska D Acta Microbiol Pol; 2002; 51(3):255-63. PubMed ID: 12588100 [TBL] [Abstract][Full Text] [Related]
30. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Bruce MG; Bruden DL; McMahon BJ; Hennessy TW; Reasonover A; Morris J; Hurlburt DA; Peters H; Sacco F; Martinez P; Swenson M; Berg DE; Parks D; Parkinson AJ Helicobacter; 2006 Dec; 11(6):581-8. PubMed ID: 17083381 [TBL] [Abstract][Full Text] [Related]
31. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. Peretz A; Paritsky M; Nasser O; Brodsky D; Glyatman T; Segal S; On A J Antibiot (Tokyo); 2014 Aug; 67(8):555-7. PubMed ID: 24781955 [TBL] [Abstract][Full Text] [Related]
32. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors]. Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289 [TBL] [Abstract][Full Text] [Related]
33. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. Branca G; Spanu T; Cammarota G; Schito AM; Gasbarrini A; Gasbarrini GB; Fadda G Int J Antimicrob Agents; 2004 Nov; 24(5):433-8. PubMed ID: 15519473 [TBL] [Abstract][Full Text] [Related]
34. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915 [TBL] [Abstract][Full Text] [Related]
35. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657 [TBL] [Abstract][Full Text] [Related]
37. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745 [TBL] [Abstract][Full Text] [Related]
38. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617 [TBL] [Abstract][Full Text] [Related]
39. The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori. Coudron PE; Stratton CW Diagn Microbiol Infect Dis; 1998 Sep; 32(1):39-44. PubMed ID: 9791756 [TBL] [Abstract][Full Text] [Related]
40. Pylera for the eradication of Helicobacter pylori infection. Saleem A; Qasim A; O'Connor HJ; O'Morain CA Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]